Trial
NCT04144335
N-803 Combined With the Broadly Neutralizing Antibodies Plus or Minus haNK Cells for HIV
Phase IWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
University of Minnesota
Collaborators
—
Condition
Hiv
Intervention
N-803 and bNAbs
Why stopped
Contact issues
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-10-22